We are live on ! Find out more

1,470 hedge funds and large institutions have $103B invested in Merck in 2013 Q3 according to their latest regulatory filings, with 78 funds opening new positions, 568 increasing their positions, 619 reducing their positions, and 53 closing their positions.

New
Increased
Maintained
Reduced
Closed

47% more first-time investments, than exits

New positions opened: 78 | Existing positions closed: 53

36% more call options, than puts

Call options by funds: $1.25B | Put options by funds: $918M

1.31% more ownership

Funds ownership: 76.5%77.81% (+1.3%)

1% more capital invested

Capital invested by funds: $102B → $103B (+$1.23B)

1% more funds holding

Funds holding: 1,4591,470 (+11)

8% less repeat investments, than reductions

Existing positions increased: 568 | Existing positions reduced: 619

3% less funds holding in top 10

Funds holding in top 10: 120117 (-3)

Holders
1,470
Holders Change
+11
Holders Change %
+0.75%
% of All Funds
47.65%
Holding in Top 10
117
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-2.5%
% of All Funds
3.79%
New
78
Increased
568
Reduced
619
Closed
53
Calls
$1.25B
Puts
$918M
Net Calls
+$331M
Net Calls Change
-$98.6M
Name Holding Trade Value Shares
Change
Change in
Stake
RHBC
1026
R.H. Bluestein & Co
Michigan
$997K -$476K -10,427 -32%
DHFB
1027
Dixon Hubard Feinour & Brown
Virginia
$996K -$9.59K -210 -0.9%
FBC
1028
Fairfield, Bush & Co
Connecticut
$993K -$235K -5,151 -19%
PFS
1029
Penseco Financial Services
Pennsylvania
$987K +$16.8K +367 +2%
NSAM
1030
North Star Asset Management
Wisconsin
$986K -$21.6K -472 -2%
BCA
1031
Benchmark Capital Advisors
New York
$981K -$57.4K -1,257 -6%
JT
1032
Jump Trading
Illinois
$978K +$983K +21,525 New
HB
1033
Homrich & Berg
Georgia
$975K +$127K +2,772 +15%
WIC
1034
Woodmont Investment Counsel
Tennessee
$973K +$56.9K +1,247 +6%
CC
1035
Courier Capital
New York
$971K -$111K -2,428 -10%
BAAM
1036
Baker Avenue Asset Management
California
$966K -$2.48M -54,416 -72%
TF
1037
Tompkins Financial
New York
$966K +$103K +2,246 +12%
PTC
1038
Philadelphia Trust Company
Pennsylvania
$963K +$12.9K +283 +1%
CDH
1039
Charles D. Hyman
$958K -$31.1K -682 -3%
AI
1040
Atria Investments
North Carolina
$957K -$289K -6,327 -23%
VKH
1041
Virtu KCG Holdings
New York
$955K +$960K +21,019 New
Alyeska Investment Group
1042
Alyeska Investment Group
Illinois
$952K +$957K +20,960 New
MBE
1043
Michael B. Elefante
$951K -$5.02K -110 -0.5%
IAS
1044
INR Advisory Services
Pennsylvania
$949K
FBB
1045
Fulton Breakefield Broenniman
Maryland
$937K +$942K +20,633 New
AHS
1046
Aspiriant Holdings S3
California
$933K +$75.2K +1,647 +9%
MFS
1047
MSI Financial Services
Massachusetts
$931K -$109K -2,391 -10%
IB
1048
Intrust Bank
Kansas
$930K -$118K -2,577 -11%
FMT
1049
First Mercantile Trust
Tennessee
$930K +$13.6K +297 +1%
WJA
1050
Williams Jones & Associates
New York
$928K -$364K -7,972 -28%

MRK Hedge Fund Activity: Q3 2013 in Review

1,470 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q3 2013, worth a combined $103B — up 1.2% from $102B a quarter earlier.

Buyers outnumbered sellers: 78 funds opened new MRK positions and 53 closed out — a net gain of 25 holders — while 568 added to existing stakes and 619 trimmed.

The largest buyer was Eagle Asset Management, adding an estimated $192M. The largest seller was Fidelity Investments, cutting an estimated $612M.

  • 1,470 institutional investors held Merck (MRK) as of Q3 2013, up from 1,459 in Q2 2013.
  • Funds reported $103B of Merck stock for Q3 2013, up 1.2% quarter-over-quarter.
  • 78 funds opened new Merck positions in Q3 2013 and 53 closed out, a net change of +25 holders.
  • The largest Merck buyer in Q3 2013 was Eagle Asset Management, an estimated $192M added.
  • The largest Merck seller in Q3 2013 was Fidelity Investments, an estimated $612M sold.

Based on aggregated 13F filings for Q3 2013.